MAPT and early-onset autosomal dominant Alzheimer disease: Cerebrospinal fluid (CSF) phosphorylated tau (p‐tau) is, together with CSF amyloid‐β 42 (Aβ42) and CSF total tau (t‐tau), a core biomarker for Alzheimer’s disease (AD).